 |
 |

DiphenylhydantoinBlocking of Levodopa Effects
Jorge S. Mendez, MD;
George C. Cotzias, MD;
Ismael Mena, MD;
Paul S. Papavasiliou, MD
Arch Neurol. 1975;32(1):44-46.
Abstract
Diphenylhydantoin (DPH) diminished the therapeutic effects of levodopa both in patients with parkinsonism and in patients with chronic manganese poisoning, as well as the levodopa-dependent dyskinesia for which the former were selected. In patients with Huntington chorea, it enhanced chorea and mental agitation and, thus, failed to conform with the postulated pharmacological reciprocity between Parkinson disease and Huntington chorea. These findings are in agreement with experiments done in animals in which DPH blocked a neuronal response to dopamine.
Author Affiliations
From the Medical Research Center, Brookhaven National Laboratory, Upton, NY.
Footnotes
Accepted for publication June 10, 1974.
Reprint requests to Medical Research Center, Brookhaven National Laboratory, Upton, NY 11973 (Dr. Cotzias).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Phenytoin and Cerebellar Lesions: Similar Effects on Cerebral Catecholamine Metabolism
Snider and Snider
Arch Neurol 1977;34:162-167.
ABSTRACT
|